ECSP13012434A - Procedimiento para preparar formas enantioméricas de derivados de ácido 2,3-diaminopropiónico - Google Patents

Procedimiento para preparar formas enantioméricas de derivados de ácido 2,3-diaminopropiónico

Info

Publication number
ECSP13012434A
ECSP13012434A ECSP13012434A ECSP13012434A EC SP13012434 A ECSP13012434 A EC SP13012434A EC SP13012434 A ECSP13012434 A EC SP13012434A EC SP13012434 A ECSP13012434 A EC SP13012434A
Authority
EC
Ecuador
Prior art keywords
alkyl
biphenyl
hydroxy
series consisting
naphthyl
Prior art date
Application number
Other languages
English (en)
Inventor
Claus-Dieter Graf
Joerg Rieke-Zapp
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43598042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP13012434(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ECSP13012434A publication Critical patent/ECSP13012434A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Un procedimiento para obtener un compuesto de fórmula I,en donde R1 es un átomo de hidrógeno, F, Cl, I, Br, alquilo(C1-C4) o -CN;R2 es un resto heteroarilo seleccionado de la serie consistente en pirrol, furano, tiofeno, imidazol, pirazol, oxazol, isoxazol, tiazol, isotiazol, tetrazol, 1,2,3,5- oxatiadiazol-2-óxidos, triazolonas, oxadiazolona, isoxazolona, oxadiazolidindiona, triazol, 3-hidroxipirrol-2,4-dionas, 5-oxo-1,2,4-tiadiazoles, piridina, pirazina, pirimidina, indol, isoindol, indazol, ftalazina, quinolina, isoquinolina, quinoxalina, quinazolina, cinolina y ?-carbolina, en donde el resto heteroarilo está sin sustituir o bien está sustituido una vez, dos veces o tres veces, de manera independiente entre sí, con sustituyentes seleccionados de la serie consistente en alquilo(C1-C5), alcoxi(C1-C5), halógeno, nitro, amino, trifluorometilo, hidroxi, hidroxi-alquilo(C1-C4), metilendioxi, etilendioxi, formilo, acetilo, ciano, hidroxicarbonilo, aminocarbonilo y alcoxi(C1-C4)-carbonilo, o un resto arilo seleccionado de la serie consistente en fenilo, naftilo, 1-naftilo, 2-naftilo, bifenililo, 2-bifenililo, 3-bifenililo, 4-bifenililo, antrilo y fluorenilo, en donde el resto arilo está sin sustituir o bien está sustituido una vez, dos veces o tres veces, de manera independiente entre sí, con sustituyentes seleccionados de la serie consistente en alquilo(C1-C5), alcoxi(C1-C5), halógeno, nitro, amino, trifluorometilo, hidroxi, hidroxi-alquilo(C1-C4), metilendioxi, etilendioxi, formilo, acetilo, ciano, hidroxicarbonilo, aminocarbonilo y alcoxi(C1-C4)-carbonilo;R3 es un átomo de hidrógeno,o alquilo(C1-C4),
ECSP13012434 2010-08-12 2013-02-08 Procedimiento para preparar formas enantioméricas de derivados de ácido 2,3-diaminopropiónico ECSP13012434A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305884 2010-08-12
US201061428336P 2010-12-30 2010-12-30

Publications (1)

Publication Number Publication Date
ECSP13012434A true ECSP13012434A (es) 2013-03-28

Family

ID=43598042

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012434 ECSP13012434A (es) 2010-08-12 2013-02-08 Procedimiento para preparar formas enantioméricas de derivados de ácido 2,3-diaminopropiónico

Country Status (23)

Country Link
US (2) US8877926B2 (es)
EP (1) EP2603491B1 (es)
JP (1) JP6000248B2 (es)
KR (1) KR20130099044A (es)
CN (1) CN103209961A (es)
AR (1) AR082621A1 (es)
AU (1) AU2011288533A1 (es)
BR (1) BR112013002985A2 (es)
CA (1) CA2807979A1 (es)
CL (1) CL2013000420A1 (es)
CO (1) CO6690757A2 (es)
CR (1) CR20130059A (es)
DO (1) DOP2013000035A (es)
EC (1) ECSP13012434A (es)
GT (1) GT201300038A (es)
MA (1) MA34464B1 (es)
MX (1) MX2013001647A (es)
PE (1) PE20131326A1 (es)
RU (1) RU2013110525A (es)
SG (1) SG187791A1 (es)
TW (1) TW201221504A (es)
UY (1) UY33552A (es)
WO (1) WO2012019967A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2787998T1 (sl) 2011-12-06 2017-02-28 Sanofi Kristalinične oblike 2-(2-metilamino-pirimidin-4-il)-1H-indol-5-karboksilne kisline ((S)-1- karbamoil-2-(fenil-pirimidin-2-il-amino)etil)-amida

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19850301A1 (de) * 1998-10-30 2000-05-04 Basf Ag Verfahren zur Racematspaltung von 2-Hydroxypropionsäuren
DE19951360A1 (de) 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
DE10237722A1 (de) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
US7462638B2 (en) 2002-08-17 2008-12-09 Sanofi-Aventis Deutschland Gmbh Use of IκB-kinase inhibitors in pain therapy
DE102004033406A1 (de) * 2004-07-10 2006-02-16 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von 2,3-Diaminopropionsäurederivaten
US20070142417A1 (en) 2005-05-11 2007-06-21 Aventis Pharmaceuticals Inc Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor
DE102005025225A1 (de) 2005-06-01 2006-12-07 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von 2-(2-Amino-pyrimidin-4-yl)-1H-indol-5-carbonsäure-derivaten

Also Published As

Publication number Publication date
US20130211085A1 (en) 2013-08-15
BR112013002985A2 (pt) 2017-11-07
JP6000248B2 (ja) 2016-09-28
PE20131326A1 (es) 2013-11-12
CN103209961A (zh) 2013-07-17
US8877926B2 (en) 2014-11-04
CR20130059A (es) 2013-03-25
EP2603491B1 (en) 2014-09-24
SG187791A1 (en) 2013-03-28
AR082621A1 (es) 2012-12-19
DOP2013000035A (es) 2013-03-15
WO2012019967A1 (en) 2012-02-16
AU2011288533A1 (en) 2013-02-28
MX2013001647A (es) 2013-03-21
CA2807979A1 (en) 2012-02-16
US9434696B2 (en) 2016-09-06
JP2013533296A (ja) 2013-08-22
UY33552A (es) 2012-03-30
GT201300038A (es) 2015-06-24
CO6690757A2 (es) 2013-06-17
RU2013110525A (ru) 2014-09-20
MA34464B1 (fr) 2013-08-01
TW201221504A (en) 2012-06-01
EP2603491A1 (en) 2013-06-19
US20150018554A1 (en) 2015-01-15
CL2013000420A1 (es) 2013-04-05
KR20130099044A (ko) 2013-09-05

Similar Documents

Publication Publication Date Title
RS51902B (sr) Derivati indola ili benzimidazola za modulaciju ikb-kinaze
Joo et al. C− H bonds as ubiquitous functionality: a general approach to complex arylated imidazoles via regioselective sequential arylation of all three C− H bonds and regioselective N-alkylation enabled by SEM-group transposition
Chaudhari et al. o-Iodoxybenzoic acid mediated oxidative desulfurization initiated domino reactions for synthesis of azoles
Li et al. Photoredox catalysis enables decarboxylative cyclization with hypervalent iodine (III) reagents: access to 2, 5-disubstituted 1, 3, 4-oxadiazoles
Fan et al. Iodine-mediated domino oxidative cyclization: one-pot synthesis of 1, 3, 4-oxadiazoles via oxidative cleavage of C (sp2)–H or C (sp)–H bond
ES2616458T3 (es) Pirimidil pirroles sustituidos activos como inhibidores de quinasas
Rogness et al. Synthesis of acridines by the [4+ 2] annulation of arynes and 2-aminoaryl ketones
Mariappan et al. Hypervalent iodine (III) mediated synthesis of 3-substituted 5-amino-1, 2, 4-thiadiazoles through intramolecular oxidative S–N bond formation
Wang et al. Aryldiazonium salts serve as a dual synthon: construction of fully substituted pyrazoles via rongalite-mediated three-component radical annulation reaction
Liu et al. Transition metal-free C (sp 3)–H bond coupling among three methyl groups
NI200900139A (es) Derivados de espirocromanona sustituidos como inhibidores de acc.
Galenko et al. Fe (II)/Au (I) relay catalyzed propargylisoxazole to pyridine isomerization: Access to 6-halonicotinates
Pathare et al. Sequential Pd (0)/Fe (III) catalyzed azide–isocyanide coupling/cyclization reaction: One-pot synthesis of aminotetrazoles
Vijay Kumar et al. Synthesis of 2-phenyl-4, 5-substituted oxazoles by copper-catalyzed intramolecular cyclization of functionalized enamides
EA200700758A1 (ru) Новые производные бис-азаиндолов, их получение и фармацевтическое применение в качестве ингибиторов киназ
WO2008051533A3 (en) Benzimidazole compounds
ECSP13012434A (es) Procedimiento para preparar formas enantioméricas de derivados de ácido 2,3-diaminopropiónico
JP2005516979A5 (es)
Fadda et al. Synthesis of Thiazolinone, Aminopyrazole, Pyrazolopyrimidine, and Pyrazolotriazine Derivatives Starting from 1‐Naphthyl‐2‐Cyanoacetamide
Marinozzi et al. One-pot, telescoped synthesis of N-aryl-5-aminopyrazoles from anilines in environmentally benign conditions
Pacifico et al. Preparation of Acidic 5-Hydroxy-1, 2, 3-triazoles via the Cycloaddition of Aryl Azides with β-Ketoesters
Pokhodylo et al. Synthesis of 2-azido-1, 3-thiazoles as 1, 2, 3-triazole precursors
Chai et al. One-pot synthesis of 3, 5-disubstituted 1, 2, 4-thiadiazoles from nitriles and thioamides via I 2-mediated oxidative formation of an N–S bond
Rauf et al. Microwave-induced synthesis of aromatic heterocycles
CO6260139A2 (es) Nuevos compuestos de ciclopentandiona activos como herbicidas y sus derivados